We have entered into a Indo European collaboration for research on Allergic diseases.
All over the globe allergic diseases are increasing . The methods of testing are also getting
revised for better diagnosis . In fact the diagnosis should be at molecular level to offer better treatment options. so far extremely purified fractions of allergens are not available  for diagnosis and treatment.
For Immunotherapy to be successful we need purified allergens which have potent immunogenicity
but do not have adverse effects while dosage are increased.
This problem is faced by scientists all over the world.
our research objective is to find methods to design purified fractions of allergens for diagnosis and treatment both. The first kick off meeting is from Oct 3 rd to 6th at IGIB Delhi where we will be meeting our European partners and rest of the group. I will be presenting some interesting data on food allergies --the clinical spectrum.